Delivery Order SPE2DB22D1017-SPE2DB24FG2GL
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,484.41 for the supply of MESALAMINE ER 0.375 GRAM CAP 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors...
This federal contract award is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $6,874.83 and an ultimate completion date of February 13, 2024. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of MESALAMINE 800 MG DR TABLET 180S to the Defense Logistics Agency (DLA). The $11,379.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of MESALAMINE ER 0.375 GRAM CAP 120S. The $3,031.10 firm-fixed-price contract has a completion date of July 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,398.31, is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 2, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a ceiling value of $7,881.82 and a period of performance through May 31, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,842.78, was awarded on February 20, 2024, and has a completion date of February 21, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,082.83 firm fixed-price delivery order is for MESALAMINE ER 0.375 GRAM CAP 120S, a specialty medication. The contract has an ultimate completion date of December 20, 2024 and was awarded on December 19, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,299.06 fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine ER 0.375 gram capsules. The contract has a ceiling value of $2,906.07 and is a firm-fixed price contract with an ultimate completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...